Multimodality treatment of patients with advanced ovarian carcinoma
- 1 October 1982
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (10) , 1671-1677
- https://doi.org/10.1016/0360-3016(82)90285-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Therapeutic intraperitoneal 32P: a clinical assessment of the dynamics of distribution.Radiology, 1981
- High-dose methotrexate with “rescue” plus cyclophosphamide as initial chemotherapy in ovarian adenocarcinoma. A randomized trial with observations on the influence ofC parvum immunotherapyCancer, 1980
- Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancerCancer Chemotherapy and Pharmacology, 1980
- Ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1979
- Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's DiseaseNew England Journal of Medicine, 1979
- Ovarian tumor antigensCancer, 1978
- The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasmaAmerican Journal of Obstetrics and Gynecology, 1978
- Maximal radiation therapy by a new treatment technique for stage III ovarian cancerInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Elevated activity of cytidine 5′-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancyBiochemical and Biophysical Research Communications, 1978
- Hematologic Neoplasia in Patients Treated for Hodgkin's DiseaseNew England Journal of Medicine, 1977